ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 103 filers reported holding ENDOCYTE INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $135,000 | -38.1% | 29,575 | -29.7% | 0.02% | -31.8% |
| Q2 2015 | $218,000 | +11.2% | 42,075 | +34.4% | 0.02% | +10.0% |
| Q1 2015 | $196,000 | -3.9% | 31,300 | -3.7% | 0.02% | -4.8% |
| Q4 2014 | $204,000 | +1.0% | 32,500 | -2.3% | 0.02% | 0.0% |
| Q3 2014 | $202,000 | +33.8% | 33,250 | +45.5% | 0.02% | +31.2% |
| Q2 2014 | $151,000 | -97.4% | 22,850 | -90.7% | 0.02% | -97.5% |
| Q1 2014 | $5,870,000 | +144.8% | 246,550 | +9.8% | 0.63% | +163.2% |
| Q4 2013 | $2,398,000 | +44.1% | 224,550 | +79.9% | 0.24% | +32.0% |
| Q3 2013 | $1,664,000 | +24.3% | 124,850 | +22.4% | 0.18% | +16.8% |
| Q2 2013 | $1,339,000 | – | 102,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |